𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab infusion time in patients with inflammatory bowel diseases: Is longer really safer?

✍ Scribed by Belhassan, Mehdi; Zeitoun, Jean-David; Lefevre, Jérémie H.; Charachon, Antoine; Amiot, Aurélien; Le Baleur, Yann; Sobhani, Iradj; Delchier, Jean-Charles

Book ID
122021620
Publisher
Elsevier
Year
2013
Tongue
French
Weight
292 KB
Volume
37
Category
Article
ISSN
2210-7401

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are accelerated infliximab infusions saf
Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?
✍ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD